logo
The ISFA wishes to acknowledge the following 2014 Corporate Sponsors
Message From the New President of the Japanese Society for Dialysis Therapy
Hemoglobin A1c in Patients on Peritoneal Dialysis: How Should We Interpret It?
Relationship Between Residual Renal Function and Serum Fibroblast Growth Factor 23 in Patients on Peritoneal Dialysis
Dialysate Vascular Endothelial Growth Factor Is an Independent Determinant of Serum Albumin Levels and Predicts Future Withdrawal From Peritoneal Dialysis in Uremic Patients
Effects of Azilsartan Compared to Other Angiotensin Receptor Blockers on Left Ventricular Hypertrophy and the Sympathetic Nervous System in Hemodialysis Patients
Low Hemoglobin Levels and Hypo-Responsiveness to Erythropoiesis-Stimulating Agent Associated With Poor Survival in Incident Japanese Hemodialysis Patients
Comparison of 2-Week Versus 4-Week Dosing Intervals of Epoetin Beta Pegol on Erythropoiesis and Iron Metabolism in Hemodialysis Patients
Changes in Hepcidin and Reticulocyte Hemoglobin Equivalent Levels in Response to Continuous Erythropoietin Receptor Activator Administration in Hemodialysis Patients: A Randomized Study
Effect of Serum Fibroblast Growth Factor-23, Matrix Gla Protein and Fetuin-A in Predicting Osteoporosis in Maintenance Hemodialysis Patients
Glycated Albumin Predicts the Risk of Mortality in Type 2 Diabetic Patients on Hemodialysis: Evaluation of a Target Level for Improving Survival
Efficacy of Coronary Artery Screening Tests and Intervention in Hemodialysis Patients
Effect of Arteriovenous Hemodialysis Shunt Location on Cardiac Events in Patients Having Coronary Artery Bypass Graft Using an Internal Thoracic Artery
Outcomes of Non-Tunneled Non-Cuffed Hemodialysis Catheters in Patients on Chronic Hemodialysis in a Resource Limited Sub-Saharan Africa Setting
Skin Autofluorescence Predicts Cardiovascular Mortality in Patients on Chronic Hemodialysis
Assessment of Dialysis Dose in Critically Ill Maintenance Dialysis Patients
Validity of a Checklist for Hemodialysis Patients Based on the International Classification of Functioning, Disability and Health
Influence of Dialysis Duration on the Outcome of Living Kidney Transplantation
Therapeutic Plasma Exchange in Glucocorticosteroid-Unresponsive Patients With Clinically Isolated Syndrome
Feasibility of Pediatric Plasma Apheresis in Intensive Care Settings
No Sustained Impact of Intermittent Extracorporeal Liver Support on Thrombocyte Time Course in a Randomized Controlled Albumin Dialysis Trial
Ultrasound Evaluation of the Effects of Leukocytapheresis on Rheumatoid Arthritis
Continuous Renal Replacement Therapy in a Patient With Pulmonary Embolism Receiving Extracorporeal Membrane Oxygenation
Successful Treatment of Enterohemorrhagic Escherichia coli O111-Induced Acute Encephalopathy and Hemolytic-Uremic Syndrome With Plasma Diafiltration
Comparison of the Effect of the Same Dose of a 4-Weekly Continuous Erythropoietin Receptor Activator Administered Once Every 2 or 4 Weeks in Hemodialysis Patients
Comparison of the Effect of the Same Dose of a 4-Weekly Continuous Erythropoietin Receptor Activator Administered Once Every 2 or 4 Weeks in Hemodialysis Patients
Upcoming Meetings